Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis.
Xu S, Wu B, Zhong B, Lin L, Ding Y, Jin X, Huang Z, Lin M, Wu H, Xu D. · 2021
Read Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. by Xu S, Wu B, Zhong B, Lin L, Ding Y, Jin X, Huang Z, Lin M, Wu H, Xu D. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8809912.txt.
Description
Xu and co-authors test naringenin, a plant flavonoid, against heart injury from restored blood flow in rats and heart cells. A death path called ferroptosis harms heart muscle in this setting. Naringenin was known to ease such injury, but its effect on ferroptosis was unreported. The team used rat hearts and a heart cell line under low-oxygen stress.
Naringenin shrank the damaged heart area and lowered inflammation markers. It cut iron buildup and oxidative stress in the tissue. It acted through a defense switch that raises a key protective enzyme. Cell tests with a ferroptosis trigger confirmed the route. The work ties a common flavonoid to a new protective mechanism.
Catalog record
| CREATOR | Xu S, Wu B, Zhong B, Lin L, Ding Y, Jin X, Huang Z, Lin M, Wu H, Xu D. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |